Although PDGFRA amplification is less common in gliomas than EGFR amplification, PDGFRA gene amplification is found in 11% of GBMs, making it the second most frequent RTK gene amplified in this family of tumors. This evidence concerns the gene PDGFRA and central nervous system cancer.